Expecting Growth in 2026 Families are not just receiving results - they are gaining the confidence and capability to ...
A 10-year study shows that a multipronged approach using whole exome sequencing can improve diagnostic yield in patients with ...
In India, rare diseases are not so rare. It is estimated that around 70 million Indians live with one of more than 7,000 rare ...
People often remark that allergies run in their family, but the genetic causes have remained unclear. Previous food allergy genetic research has relied upon broad but surface-level methods called ...
2h
SickKids helping to expand access to genomic using the C-GUIDE measurement tool in the iHope program
SickKids is providing the C-GUIDE™ tool evaluation of iHope's genomic testing for the diagnosis, care, and well-being ...
A Florida state legislator sponsored the nation's first state-backed genetic screening program after his son died from a rare genetic disease.
Milestone highlights growing adoption of DNA and RNA-informed diagnostics for hereditary cancer and rare disease ALISO VIEJO, Calif., February 02, 2026--(BUSINESS WIRE)--Ambry Genetics, a leader in ...
Ambry Genetics, a leader in clinical genomic testing, and now a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM), announced the completion of its one-millionth DNA/RNA test, underscoring the ...
Milestone highlights growing adoption of DNA and RNA-informed diagnostics for hereditary cancer and rare disease Ambry Genetics, a leader in clinical genomic testing, and now a wholly owned subsidiary ...
Milestone highlights growing adoption of DNA and RNA-informed diagnostics for hereditary cancer and rare disease ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics, a leader in clinical genomic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results